reference/14868137

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14868137

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	78572
issn	1949-2553
issueIdentifier	45
pageRange	78556-78572
publicationName	Oncotarget
startingPage	78556
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fb9fe2ddc77a8f19dd83b82a4cfe0ef0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_72c7d613bd333ca0b09f2d8163b43cc3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_50b905ee665273a5caef7adb11624c40 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bfdefa416740df6b06ad570c91c62ce1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_66bd815a9110b0f327580d74f72128c9
bibliographicCitation	Grant TJ, Mehta AK, Gupta A, Sharif AAD, Arora KS, Deshpande V, Ting DT, Bardeesy N, Ganem NJ, Hergovich A, Singh A. STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines. Oncotarget. 2017 Oct 03;8(45):78556–72. PMID: 29108249; PMCID: PMC5667982.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1787c57b57ffa1abae436f259128cc95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e0983285c6a75b8b2f81c22f919d604 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b30d5bc48127e588ec31129b75e16dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf1797a142a0e55afe000e74cf185382 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4705-8683 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7cd3c18af3362f4a40d07af73bd4afd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_964a46c16d87a62e51ec562b96dd378b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dde05c8cf0075f64e87376f54aa3631f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_328670ce3fa5888fa717edda2d2f1cfb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f06d9a79906d262f7ef1878d7b8ecf95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c709e4ab134232438940999e92aaa08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_801a38ddeb0b5a88ac5526f68a85ad24
date	2017-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.18632/oncotarget.20833 https://pubmed.ncbi.nlm.nih.gov/29108249 https://pubmed.ncbi.nlm.nih.gov/PMC5667982
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803 https://portal.issn.org/resource/ISSN/1949-2553
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_24fcc8ae2c4a3fc4fe2b5ecda59a20f4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_441f4fb8318f243ac0b605ca00746789 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_582d5f2f504253c89e3a8210d6134600 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d10e42cf26918b84b09b9666105492d4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75be19437755fc2af3f5756d6bb1d737 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf99a94c673fe4e93461af6be7e99f9e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d628a25e892b9935143372f9882c544 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_614c90233c24afed5c4f1b5125cc6e74

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23012

Total number of triples: 50.